NMDA antagonist prodrugs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9822075
SERIAL NO

15034727

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Prodrugs of an NMDA antagonist, (S)-1-phenyl-2-(pyridin-2-yl)ethanamine, useful for the treatment of depression (particularly major depressive disorder) or pain; compositions comprising them, and methods of making them.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTRAZENECA ABSWEDISH SODERTALJE SODERTALJE STOCKHOLM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Balestra, Michael New Fairfield, US 18 129
Bernstein, Peter Robert Rose Valley, US 14 119
Hogdin, Katharina Knivsta, SE 8 117
Kers, Annika Malmö, SE 35 242
Malmborg, Per Jonas Linköping, SE 4 3
Nordvall, Gunnar Rönninge, SE 37 175
Quirk, Michael Acton, US 4 3
Weigelt, Dirk Reinhold Rönninge, SE 4 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 21, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 21, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00